Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 21.60
Change Today 0.00 / 0.00%
Volume 0.0
GEFEN On Other Exchanges
Symbol
Exchange
Tel Aviv
As of 10:24 AM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

gefen biomed investment ltd (GEFEN) Snapshot

Open
$21.80
Previous Close
$21.80
Day High
$21.60
Day Low
$18.90
52 Week High
06/21/15 - $23.50
52 Week Low
07/6/14 - $11.60
Market Cap
15.0M
Average Volume 10 Days
14.8K
EPS TTM
$0.17
Shares Outstanding
69.4M
EX-Date
12/1/99
P/E TM
1.2x
Dividend
--
Dividend Yield
--
Current Stock Chart for GEFEN BIOMED INVESTMENT LTD (GEFEN)

Related News

No related news articles were found.

gefen biomed investment ltd (GEFEN) Related Businessweek News

No Related Businessweek News Found

gefen biomed investment ltd (GEFEN) Details

Gefen Biomed Investments Ltd engages in the location, screening, and investment in early-stage biotechnology and medical technology companies. The company holds two incubators, ATI in Ashkelon and Meytav in Tel Hay. The ATI incubator involves in technology scouting and start-up development in the fields of healthcare and clean technology. The Meytav focuses on the life science sector, including biopharmaceuticals and medical devices. Gefen Biomed Investments Ltd also finances and supports start-ups in the field of renewable and alternative energy, and energy-saving technologies. Its portfolio includes various therapeutic areas, such as orthopedics, general surgery, dental, CNS, and drug delivery. The company is based in Ashkelon, Israel.

gefen biomed investment ltd (GEFEN) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: 434.5K
Controller
Total Annual Compensation: 267.7K
Managing Director and Director
Total Annual Compensation: --
Vice President of Investors Relations and Dir...
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

gefen biomed investment ltd (GEFEN) Key Developments

Gefen Biomed Investments Ltd, Special/Extraordinary Shareholders Meeting, May 11, 2015

Gefen Biomed Investments Ltd, Special/Extraordinary Shareholders Meeting, May 11, 2015., at 10:00 Israel Standard Time.

Gefen Biomed Investments Ltd Auditor Raises 'Going Concern' Doubt

Gefen Biomed Investments Ltd filed its Annual on Mar 03, 2015 for the period ending Dec 31, 2014. In this report its auditor, Kesselman & Kesselman, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Gefen Biomed Investments Ltd, Special/Extraordinary Shareholders Meeting, Dec 03, 2014

Gefen Biomed Investments Ltd, Special/Extraordinary Shareholders Meeting, Dec 03, 2014., at 10:00 Israel Standard Time.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GEFEN:IT 21.60 0.00

GEFEN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for GEFEN.
View Industry Companies
 

Industry Analysis

GEFEN

Industry Average

Valuation GEFEN Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GEFEN BIOMED INVESTMENT LTD, please visit www.gefenbiomed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.